Delivery Order SPE2DB20D3103-SPE2DB24FN0X3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.95 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. This award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,856.62 Delivery Order award is for the provision of Emtricitabine-Tenofovir 200-300 mg prescription medication. The contract has a completion date of June 30, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,210.20, is a delivery order contract for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has a completion date of May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The $1,053.16 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that was awarded to the parent company, Cencora, Inc., doing business as Amerisourcebergen. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.39 Firm Fixed Price Delivery Order (Contract #: SPE2DB20D1109|SPE2DB23FN23R) is for the delivery of Emtricitabine-Tenofovir 200-300mg medications, with a completion date of December 28, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of pharmaceutical products, including Emtricitabine-Tenofovir 200-300mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,152.78 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The federal contract award detailed is for the delivery of Emtricitabine-Tenofv 200-300mg pharmaceuticals, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,146.50 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a Defense agency, with a period of performance through June 14, 2023. The contract is not designated under any set-aside program. Amerisourcebergen holds significant Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN0X3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,050.83 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB24FN0X3) is for the supply of emtricitabine-tenofovir 200-300 mg tablets. The award has a completion date of March 20, 2024 and does not include any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/19/24 |